These positive results from the aforementioned studies shed new light on the therapeutic use of CBD for tremors. Products like CBD oil can significantly improve motor disorders without the dangerous side effects associated with pharmaceuticals.
CBD oil is administered under the tongue. From there, it absorbs through tiny blood vessels in the mouth, reaching the bloodstream. The effects of CBD oil are usually noticeable within 15-30 minutes after administration, lasting for up to 6 hours. The peak concentration levels of CBD oil are usually reached after 1.5 hours. The bioavailability of CBD oil is around 35%, meaning that slightly over one-third of the ingested content ends up in your system.
When CBD regulates these receptors, it produces relaxing and antispasmodic effects; it can also block the release of pro-inflammatory proteins known to damage the nervous system.
Scientists have been examining the health benefits of CBD for quite some time now, with great effort being fueled into research on how CBD may affect tremors.
Bottom Line: How Can You Use CBD to Help with Tremors?
Tremors can be caused by various factors, from neurodegenerative diseases to anxiety, brain damage, aging, and withdrawal symptoms from addiction.
Nina created CFAH.org following the birth of her second child. She was a science and math teacher for 6 years prior to becoming a parent — teaching in schools in White Plains, New York and later in Paterson, New Jersey.
The endocannabinoid system (ECS) controls an array of essential physiological processes, including motor functions and movement. Since tremors are muscle movements that involve back and forth rhythmic swaying, they perfectly fall into that bracket.
CBD Oil vs. Capsules for Essential Tremors
Many of the prescription drugs that people usually take for tremors carry a risk of dangerous side effects. CBD, in turn, comes with anti-tremor properties and has a good safety profile with only minor side effects when overdosed.
CBD oil is the modulator of the ECS, but can it help with tremors?
This is exactly why the IETF is so pleased to support Dr. Handforth and this cutting-edge research with a nearly $20,000 grant. “The significance of this work is two-fold,” says Dr. Handforth. “First, finding that CBD suppresses tremor in an animal model may provide justification for a clinical trial of CBD for essential tremor in humans. Second and more importantly, if we can understand how CBD stops the tremor, what mechanisms are at work, then an ET-specific medication could be developed that would be better-tolerated and more effective than what it available today.”
Principle Investigator: Adrian Handforth, MD
Cannabidiol Anti-Tremor Action & Mechanisms – Conclusion
Cannabis, also known as marijuana, has been used for medicinal purposes for thousands of years. However, by federal law, the possession of cannabis is illegal in the United States, except within approved research settings; however, a growing number of states, territories, and the District of Columbia have enacted laws to legalize its medical use.
An ET-specific medication would impact millions of people around the world who have this life-altering condition but who don’t respond to the medications that are currently available. An ET-specific medication would be a life-changer for millions of men, women and children today and for generations to come.
Essential tremor (ET) is a common clinical syndrome characterized by action tremors affecting both upper limbs that can compromise manual tasks’ execution and impair functional and social performance. The primary pharmacological treatment is symptomatic, but effective medicines are somewhat limited. There is a clear need to find new effective therapies for the treatment of ET. Cannabidiol (CBD) is a modulator of CB1 receptor and CB1 agonists can reduce tremors in experimental models. We hypothesized that a single acute CBD intake would reduce tremors in ET patients. We performed a randomized, controlled, double-blind, crossover study on 19 patients with ET. They were 10 males and 9 females, had mean 63 years of age, and mean 23 years of disease duration and had insufficient control of their tremors with the usual pharmacological treatment. They ingested a single oral dose of CBD (300 mg) or placebo in two experimental sessions performed 2-weeks apart. Patients were evaluated immediately before and after oral ingestion (60 min and 210 min), using the Fahn-Tolosa-Marin clinical scale. There was no carryover effect. There were no significant differences in upper limb tremors score, specific motor task tremor scores (writing and drawing/pouring) or clinical impression of change after treatment with placebo or CBD. In conclusion, a single 300 mg oral dose of CBD had no significant effect on the severity of upper limb tremors of ET patients. Our findings did not exclude the possibility that chronic treatment with CBD could have a symptomatic effect.